Sales of CooperVision in the Americas, which represented 43% of CVI revenues, increased 13% to $158.5 million. Sales in the EA region, which account for 40% of CVI revenues in the quarter, climbed 25% to $147.6 million.CooperVision’s multifocal business grew by 26% in the first quarter with sales of $42 million while sales of single-use spheres increased by 22% to reach sales of $84.2 million. CVI’s largest segment, torics, rose 7% to $108.5 million.Commenting on the results, Mr Robert Weiss, Cooper’s president and chief executive officer, said: We’ve started fiscal 2015 with a strong quarter. In addition to solid operational performance, our integration of Sauflon is going very well along with our US launch of Clariti.Although currency continues to create headwinds, we’re raising our EPS guidance and rain very enthusiastic about our prospects for the rainder of the year, and into the future.
Three Australasian ophthalmologists feature in new-look 2025 Power List
Three ophthalmologists from Australia and New Zealand have been ranked among the top in their field as part of a...
